JCR Pharmaceuticals.
$4.17
3
-$0.08-1.88% Monday 20:00
Statistics
Day High
4.17
Day Low
4.17
52W High
5
52W Low
3.78
Volume
-
Avg. Volume
-
Mkt Cap
540.79M
P/E Ratio
-
Dividend Yield
1.62%
Dividend
0.07
Upcoming
Dividends
1.62%Dividend Yield
Mar 26
$0.06
Dec 25
$0.07
Jun 25
$0.07
Dec 24
$0.07
Jun 24
$0.07
10Y Growth
10.79%
5Y Growth
-3.09%
3Y Growth
-2.75%
1Y Growth
-2.73%
Earnings
13MayExpected
Expected EPS
-0.04175574
Actual EPS
N/A
Financials
-3.51%Profit Margin
Unprofitable796.32MRevenue
-27.97MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow JCRRF. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
JCR Pharmaceuticals Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease. The company develops Epoetin Alfa BS and Darbepoetin Alfa BS Injections for the treatment of renal anemia. In addition, it sells, imports, and exports medical devices; and purchases and sells medical and research equipment. The company has a collaboration agreement with Angelini Pharma for the development of novel biologic therapies; and a. joint research agreement with Modalis Therapeutics Corporation to evaluate the drug delivery technology of the gene therapy to the central nervous system (CNS) assuming CNS diseases as a target. The company was founded in 1975 and is based in Ashiya, Japan.
Show more...
CEO
Mr. Shin Ashida
Employees
934
Country
Japan
ISIN
JP3701000006
Listings
0 Comments
Share your thoughts
FAQ
What is JCR Pharmaceuticals. stock price today?▼
The current price of JCRRF is $4.17 USD — it has decreased by -1.88% in the past 24 hours. Watch JCR Pharmaceuticals. stock price performance more closely on the chart.
What is JCR Pharmaceuticals. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange JCR Pharmaceuticals. stocks are traded under the ticker JCRRF.
What is JCR Pharmaceuticals. market cap?▼
Today JCR Pharmaceuticals. has the market capitalization of 540.79M
When is the next JCR Pharmaceuticals. earnings date?▼
JCR Pharmaceuticals. is going to release the next earnings report on May 13, 2026.
What were JCR Pharmaceuticals. earnings last quarter?▼
JCRRF earnings for the last quarter are 0 USD per share, whereas the estimation was -0.01 USD resulting in a +125.19% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is JCR Pharmaceuticals. revenue for the last year?▼
JCR Pharmaceuticals. revenue for the last year amounts to 796.32M USD.
What is JCR Pharmaceuticals. net income for the last year?▼
JCRRF net income for the last year is -27.97M USD.
Does JCR Pharmaceuticals. pay dividends?▼
Yes, JCRRF dividends are paid semi-annual. The last dividend per share was 0.06 USD. As of today, Dividend Yield (FWD)% is 1.62%.
How many employees does JCR Pharmaceuticals. have?▼
As of April 19, 2026, the company has 934 employees.
In which sector is JCR Pharmaceuticals. located?▼
JCR Pharmaceuticals. operates in the Health & Wellness sector.
When did JCR Pharmaceuticals. complete a stock split?▼
The last stock split for JCR Pharmaceuticals. was on September 29, 2020 with a ratio of 4:1.
Where is JCR Pharmaceuticals. headquartered?▼
JCR Pharmaceuticals. is headquartered in Ashiya, Japan.